|
- Mylan - Now a Part of Viatris
Mylan is now part of Viatris, a new global healthcare company committed to empowering people to live healthier at every stage of life We encourage you to learn more about our commitment to increasing access to quality medicines for patients when and where they need them
- Mylan Investor Relations | Mylan N. V.
The Investor Relations website contains information about Mylan N V 's business for stockholders, potential investors, and financial analysts
- Viatris Production - Sign In - Mylan
Connecting to Sign in with your account to access Citrix Netscaler Gateway - apps1 mylan com
- News Archive | Mylan N. V.
Sep 15, 2020 Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone® 40mg mL Sep 15, 2020 Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn Sep 09, 2020 Mylan to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference Sep
- Mylan - About the Offer
You can access Mylan's filings with the SEC through the SEC website at www sec gov, and Mylan strongly encourages you to do so Mylan undertakes no obligation to update any statements herein for revisions or changes after the date of the communications on this website, except as required by law
- Past Events Presentations - Mylan N. V.
Mylan N V is continuing to expand its shareholder engagement activities and expects to discuss this presentation during upcoming meetings The presentation is also available on the Champion for Global Health website https: www championforglobalhealth com en progress investor-presentations
- Viatris Reveals Branding to Reflect New Companys . . . - Mylan N. V.
HERTFORDSHIRE, England, PITTSBURGH and NEW YORK, July 9, 2020 PRNewswire -- Mylan N V (NASDAQ: MYL) and Upjohn, a division of Pfizer, today unveiled the logo and branding for VIATRIS ™, the new company that will be formed by combining Mylan and Upjohn
- FOR IMMEDIATE RELEASE - medatransaction. mylan. com
You can access Mylan’s filings with the SEC through the SEC website at www sec gov, and Mylan strongly encourages you to do so Mylan undertakes no obligation to update any statements herein for revisions or changes after the date of this communication, except as required by law
|
|
|